salesforce.com (CRM) Tops Q2 EPS by 1c; Raises Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
salesforce.com (CRM) PT Raised to $110 at Canaccord Genuity on 2Q Beat; 'Good Print, Conservative Q3 Deferred Guide... If Stock Stays Down, Buy It'
August 23, 2017 10:26 AM EDTCanaccord Genuity raised its price target on salesforce.com (NYSE: CRM) to $110.00 (from $100.00) while maintaining a Buy rating, following the company's second quarter earnings report.
Analyst Richard Davis notes the company delivered second quarter earnings per share, revenue, billing and free cash flow results... More
salesforce.com (CRM) PT Raised to $105 at BMO Capital on 2Q Report; 'Raise Our Confidence in CRM to Sustain Almost 20% Revenue Growth'
August 23, 2017 8:58 AM EDTBMO Capital raised its price target on salesforce.com (NYSE: CRM) to $105.00 (from $100.00) while maintaining a Outperform rating, following the company's second quarter earnings report.
Analyst Keith Bachman notes the company delivered second quarter earnings per share and revenue results above consensus projections,... More
salesforce.com (CRM) PT Raised to $84 at Jefferies
August 23, 2017 6:53 AM EDTJefferies raised its price target on salesforce.com (NYSE: CRM) to $84.00 (from $80.00) while maintaining a Hold rating following Q2 results which showed top-line momentum. The said bottom-line future remains unclear.
Analyst John DiFucci commented, "CRM exceeded F2Q expectations for all... More
salesforce.com (CRM) PT Raised to $110 at Mizuho Securities
August 23, 2017 6:10 AM EDTMizuho Securities raised its price target on salesforce.com (NYSE: CRM) to $110.00 (from $100.00) while maintaining a Buy rating following solid Q2 results.
Analyst Abhey Lamba highlighted that deferreds and off-balance sheet backlog performance was very strong, owing to ongoing share gains and... More
